Instrument Inactif

Communiqués PLx Pharma Winddown Corp.

Actions

PLXP

US72942A1079

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

PLx Pharma : Material Agreement - Form 8-K	27/05/23	PU
PLx Pharma : Bankruptcy - Form 8-K	13/04/23	PU
PLX PHARMA INC. : Bankruptcy or Receivership, Financial Statements and Exhibits (form 8-K)	13/04/23	AQ
PLX PHARMA INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	12/04/23	AQ
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets	12/04/23	AQ
PLx Pharma Inc. Receives Nasdaq Delisting Notice	11/04/23	AQ
PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	10/04/23	AQ
PLX PHARMA INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	08/03/23	AQ
PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	13/02/23	AQ
PLX PHARMA INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	20/01/23	AQ
PLX PHARMA INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	10/11/22	AQ
PLX PHARMA INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	10/11/22	AQ
PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update	10/11/22	AQ
PLx Pharma Inc. to Report Third Quarter 2022 Financial Results on November 11, 2022, and Provide Business Update	26/10/22	AQ
PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	07/10/22	AQ
Baseball Legend John Smoltz Featured on PLx Pharma’s Social Channels	12/09/22	AQ
PLX PHARMA INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	12/08/22	AQ
PLx Pharma : Reports Second Quarter 2022 Results and Provides Business Update - Form 8-K	12/08/22	PU
PLX PHARMA INC. : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)	12/08/22	AQ
Survey: Cardiovascular Patients on Aspirin Therapy Prefer VAZALORE® 81 mg	12/08/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués PLx Pharma Winddown Corp.

Actions

PLXP

US72942A1079

Communiqués

Filtres